EndoGastric Solutions has announced it completed raising $30 million in an internal series G financing round.
EndoGastric, headquartered in San Mateo, Calif., develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases.
Existing investors including Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors and Radius Ventures participated in the financing round.
EndoGastric said it intends to use the funding to support publishing data from three randomized trials, bring new products to market and establish clear reimbursement for its technology.